GI Disorders
Low-FODMAP Diet: Helpful or Harmful in IBS?
A diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols is one of the recommended ...
APRIL 28, 2026
Higher-Cost Specialty Therapies Make a Move Toward Front-Line Status
Specialty therapies like IL-23 and JAK inhibitors are moving into earlier treatment lines, reshaping care and ...
APRIL 24, 2026
GI Disorders Often Fueled by the Human Body’s ‘Second Brain’
The gut–brain–microbiome axis is a two-way street, with GI symptoms affected by stress and acting as a ...
AUGUST 22, 2025
FMT May Boost Immunotherapy Effectiveness
Fecal microbiota transplantation may enhance the effectiveness of immunotherapies by reducing gut dysbiosis, ...
JULY 24, 2025
Tevimbra Approved for Some Patients With Unresectable or Metastatic ESCC
The FDA has approved Tevimbra, in combination with platinum-containing chemotherapy, for the first-line treatment ...
MARCH 4, 2025
FDA Approves Lumakras With Vectibix for KRAS G12C–Mutated Colorectal Cancer
The FDA has approved Lumakras with Vectibix for adult patients with KRAS G12C–mutated metastatic colorectal ...
JANUARY 21, 2025
Tevimbra Approved for Treatment of Gastric and Gastroesophageal Junction Cancers in Combination With Chemo
The FDA has approved Tevimbra, in combination with platinum and fluoropyrimidine-based chemotherapy, for the ...
JANUARY 13, 2025
A Miss for FMT in Ulcerative Colitis, Additional Upadacitinib Benefits in Crohn’s
This month’s report looks at two distinct issues: fecal microbiota transplantation and upadacitinib.
SEPTEMBER 27, 2024
New Guideline for H. pylori Changes Primary Treatment Recommendation
The American College of Gastroenterology updated its 2017 guideline for treating Helicobacter pylori.
SEPTEMBER 24, 2024
Machine Learning Can Predict Best Responders to GLP-1s
Machine learning tools can sift through genetic profiles to predict which patients with obesity will best respond ...
SEPTEMBER 21, 2024
FDA Approves Guselkumab for UC
The FDA has approved Tremfya for patients with moderately to severely active ulcerative colitis.
SEPTEMBER 12, 2024
ACG Issues Updated Guidance on Alcohol-Associated Liver Disease
The American College of Gastroenterology recently published a guideline on alcohol-associated liver disease.
AUGUST 15, 2024
